Back

Safety and efficacy of transcatheter left atrial appendage closure using the novel Lifetech LAmbretm occluder in patients with nonvalvular atrial fibrillation

21 June 2017 (08:00 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - New implantable devices Automatic implantable cardioverter / defibrillator EHRA Premium Access EHRA EUROPACE - CARDIOSTIM 2017

About the speaker

Photo
Professor Nico Reinsch

Alfried-Krupp-Hospital Ruttenscheid, Essen (Germany)

2 More presentations in this session

Presentation thumbnail
Doctor S. Teman Yarden (Ramat Gan, IL)
Abstract Slides
Presentation thumbnail
Doctor M. Sasov (Bratislava, SK)
Abstract

Access the full session

Session thumbnail
Poster session 4 - New implantable devices

The Event

Event poster

EHRA EUROPACE - CARDIOSTIM 2017

21 June 2017 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial appendage closure in atrial fibrillation: gaps in knowledge
1 September 2025
thumbnail
Congress Presentation
A novel bionic constructional left atrial appendage occlude device: the result of preclinical experiment and first-in-human study
30 August 2024
thumbnail
Congress Presentation
One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices
27 August 2021
thumbnail
Congress Presentation
Direct oral anticoagulants versus left atrial appendage closure in elderly patients (>80) with atrial fibrillation: results from a propensity matched analysis in real-life patients
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources